Search

Search Constraints

You searched for: Author/Creator Pujade-Lauraine, Eric

Search Results

1. 2022-RA-1088-ESGO Chitinase response after 3 cycles of chemotherapy as a promising marker of chemosensitivity an ancillary analysis of the GINECO-ENGOT EWOC-1 trial. (20th October 2022)

2. 2022-RA-935-ESGO Development of an academic genomic instability score for ovarian cancers. (20th October 2022)

3. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Issue 1 (1st January 2016)

4. Advances and Concepts in Cervical Cancer Trials: A Road Map for the Future. Issue 1 (January 2016)

6. Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study. Issue 11 (November 2021)

7. Avelumab Alone or in Combination With Chemotherapy Versus Chemotherapy Alone in Platinum-Resistant or Platinum-Refractory Ovarian Cancer (JAVELIN Ovarian 200): An Open-Label, Three-Arm, Randomised, Phase 3 Study. Issue 11 (November 2021)

8. Avelumab alone or in combination with chemotherapy versus chemotherapy alone in platinum-resistant or platinum-refractory ovarian cancer (JAVELIN Ovarian 200): an open-label, three-arm, randomised, phase 3 study. Issue 7 (July 2021)

9. Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord–Stromal Tumors: A Systematic Review and Meta-analysis. Issue 9 (1st November 2015)

10. Bleomycin-Induced Pneumonitis in the Treatment of Ovarian Sex Cord–Stromal Tumors: A Systematic Review and Meta-analysis. Issue 9 (November 2015)